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Introduction
Neuroendocrine adenomas of the middle ear (NEAME) are 
rare tumors.1-4 Whereas neuroendocrine cells are normally 
found in the lung and gastrointestinal tract, they are nor-
mally not found in the middle ear (ME) mucosa.1-6 Although 
neuroendocrine tumors were initially believed to originate 
from the neuroendocrine cell system, it is now known that 
they may originate from tissue that lacks neuroendocrine 
cells, such as the ME mucosa, because these tumors are de-
rived from pluripotent stem cells that are capable of neuro-
endocrine differentiation.1,5 
Case presentation
A 27-year-old female presented with a three-month history of 
fullness in the right ear. The patient visited a local hospital 
and was diagnosed as congenital cholesteatoma. The patient 
was referred to this hospital. Upon otoscopic examination, 
the right tympanic membrane (TM) was found to be bulging, 
with a whitish ME mass (fig. 1A). Pure tone audiometry reve-
aled air and bone conduction thresholds of 20 and 12.5dB HL, 
respectively, on the right side. However, the thresholds at 
4 kHz and 8 kHz were elevated. The computed tomography 
(CT) scan showed soft tissue density in the ME cavity, and 
there was no evidence of bony destruction (fig. 1B).
A canal wall up mastoidectomy and tympanoplasty 
were performed. During the operation, a soft, pale, well-
-encapsulated mass was found filling the tympanum and 
encasing the stapes. The incus and stapes were extracted 
for complete removal of tumor. The footplate of the sta-
pes was repositioned; the incus was remodeled and then 
positioned on the stapes footplate. The specimen was soft 
and relatively tougher than cholesteatoma, and there was 
no keratin material. 
The histopathologic results revealed a well-differentia-
ted neuroendocrine neoplasm. Routine light microscopy re-
vealed a proliferation of small monotonous cells arranged 
in trabecular patterns. There were no findings of necrosis, 
nuclear atypia, and mitosis (fig. 1C). Immunohistochemical 
stainings were positive for chromogranin, synaptophysin, 
neuron specific enolase, vimentin, CD56, and cytokeratin 
(fig. 1D-E). 
The final diagnosis was revised from congenital choles-
teatoma to NEAME. The patient did not present any symp-
toms related to carcinoid syndrome. Chest and abdominal 
CT were performed, as well as an assessment of the urinary 
catecholamines and their metabolites for investigating dis-
tant metastases and simultaneous carcinoid tumor in other 
organs. The catecholamines and their metabolites were fou-
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nd within the normal limits and chest and abdominal CT did 
not reveal any mass lesions. The patient has been followed 
for 30 months without evidence of recurrent disease.
Discussion
NEAME can be confused with glomus tympanicum and con-
genital cholesteatoma, as was the case with the present 
patient. It is difficult to diagnose NEAME before the final 
histological examination, since the clinical manifestations 
and radiographic findings are nonspecific. 
The pathologic diagnosis of NEAME is primarily based on 
light microscopy with hematoxylin-eosin staining; the diag-
nosis is confirmed by immunohistochemical investigation.1,2 
On immunohistochemical staining, epithelial markers inclu-
de cytokeratins, and neuroendocrine markers include chro-
mogranin, synaptophysin, neuron specific enolase, vimen-
tin, and CD56.5 Angouridakis et al. suggested that NEAME 
were positive for epithelial and neuroendocrine markers, 
while carcinoid tumors of the ME were negative for epi-
thelial markers and positive for neuroendocrine markers.6 
Saliba et al. proposed that NEAME were positive for immu-
nohistochemistry and there was no evidence of metastasis, 
whereas carcinoid tumors of the ME were positive for immu-
nohistochemistry and there was evidence of metastasis or 
carcinoid syndrome.5 In the present case, the tumor cells 
were positive for epithelial marker and neuroendocrine 
markers. There was no evidence of metastasis and carcinoid 
syndrome. Therefore, the tumor of present case is best des-
cribed by the term NEAME.5,6 
Final remarks
NEAME are uncommon. The diagnosis of NEAME is made by 
the presence or absence of immunohistochemical markers, 
metastases, and carcinoid syndrome. 
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Figure 1 A, Preoperative otoscopic finding shows whitish mass 
behind the tympanic membrane. B, Preoperative axial view of 
temporal bone CT shows soft tissue density in the middle ear 
cavity. C, Tumor is composed of trabeculars lined by multiple 
layers of small and monotonous cells with an intraluminal 
eosinophilic secretion (H&amp; E stain ×200). D, Immunohisto-
chemical stain for chromogranin shows strong positivity within 
tumor cells (chromogranin × 400). E, Immunohistochemical 
stain for synaptophysin shows strong positivity within tumor 
cells (synaptophysin × 400).
